(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUESTS:
Bloomberg healthcare reporter Cynthia Koons on Pfizer buying eczema drugmaker Anacor for $5.2 billion.

John Kilduff, Founding partner of Again Capital, on the oil markets, and the rally:  is the global supply glut really over?

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUESTS:
Bloomberg healthcare reporter Cynthia Koons on Pfizer buying eczema drugmaker Anacor for $5.2 billion.

John Kilduff, Founding partner of Again Capital, on the oil markets, and the rally:  is the global supply glut really over?</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Bloomberg’s Koons on Pfizer, Again’s Kilduff on Oil  (Audio)

Bloomberg's Koons on Pfizer, Again's Kilduff on Oil  (Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d081306b-f65e-4c8e-866f-ae3c00ab6f60/transcript

Advertisement